We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA TO IMPOSE HOLDS IN CASES OF CLINICAL MISCONDUCT
FDA TO IMPOSE HOLDS IN CASES OF CLINICAL MISCONDUCT
September 9, 2004
The FDA will impose a partial or complete clinical hold on research studies involving human drugs and biologics in cases where a clinical investigator has committed serious violations of FDA regulations or submitted false data to the agency or trial sponsor.